Lipigon Pharmaceuticals AB (publ) (STO:LPGO)
Sweden
· Delayed Price · Currency is SEK 0.0029
-0.0003 (-9.38%)
Apr 29, 2026, 4:44 PM CET
STO:LPGO Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Cash & Equivalents | 10.21 | 11.78 | 31.93 | 9.64 | 28.47 | Upgrade
|
| Cash & Short-Term Investments | 10.21 | 11.78 | 31.93 | 9.64 | 28.47 | Upgrade
|
| Cash Growth | -13.26% | -63.12% | 231.30% | -66.15% | 126.81% | Upgrade
|
| Accounts Receivable | - | 1.09 | - | - | 0.1 | Upgrade
|
| Other Receivables | 0.6 | 0.96 | 1.25 | 0.97 | 0.49 | Upgrade
|
| Receivables | 0.6 | 2.05 | 1.25 | 0.97 | 0.59 | Upgrade
|
| Prepaid Expenses | 0.42 | 0.77 | 0.38 | 0.09 | 0.11 | Upgrade
|
| Other Current Assets | 0 | 0 | - | 0.05 | 0.17 | Upgrade
|
| Total Current Assets | 11.24 | 14.6 | 33.55 | 10.74 | 29.33 | Upgrade
|
| Property, Plant & Equipment | 0.25 | 0.23 | 0.05 | 0.07 | 0.1 | Upgrade
|
| Total Assets | 11.49 | 14.82 | 33.6 | 10.82 | 29.43 | Upgrade
|
| Accounts Payable | 2.08 | 4.77 | 2.43 | 3.49 | 5.29 | Upgrade
|
| Accrued Expenses | 1.18 | 2.05 | 1.77 | 3.35 | 1.07 | Upgrade
|
| Other Current Liabilities | 0.32 | 0.24 | 0.96 | 0.11 | 0.11 | Upgrade
|
| Total Current Liabilities | 3.57 | 7.06 | 5.16 | 6.95 | 6.47 | Upgrade
|
| Other Long-Term Liabilities | 0 | 0 | -0 | - | - | Upgrade
|
| Total Liabilities | 3.57 | 7.06 | 5.16 | 6.95 | 6.47 | Upgrade
|
| Common Stock | 0.79 | 0.59 | 14.25 | 2.28 | 1.1 | Upgrade
|
| Additional Paid-In Capital | 163.92 | 131.59 | 127.55 | 102.82 | 85.39 | Upgrade
|
| Retained Earnings | -156.79 | -124.41 | -113.36 | -101.23 | -63.52 | Upgrade
|
| Comprehensive Income & Other | 0 | -0 | 0 | - | - | Upgrade
|
| Shareholders' Equity | 7.91 | 7.76 | 28.45 | 3.87 | 22.96 | Upgrade
|
| Total Liabilities & Equity | 11.49 | 14.82 | 33.6 | 10.82 | 29.43 | Upgrade
|
| Net Cash (Debt) | 10.21 | 11.78 | 31.93 | 9.64 | 28.47 | Upgrade
|
| Net Cash Growth | -13.26% | -63.12% | 231.30% | -66.15% | 126.81% | Upgrade
|
| Net Cash Per Share | 0.03 | 0.09 | 0.50 | 0.66 | 3.16 | Upgrade
|
| Filing Date Shares Outstanding | 605.93 | 148.33 | 126.42 | 20.24 | 9.73 | Upgrade
|
| Total Common Shares Outstanding | 605.93 | 148.33 | 126.42 | 20.24 | 9.73 | Upgrade
|
| Working Capital | 7.66 | 7.54 | 28.4 | 3.8 | 22.87 | Upgrade
|
| Book Value Per Share | 0.01 | 0.05 | 0.22 | 0.19 | 2.36 | Upgrade
|
| Tangible Book Value | 7.91 | 7.76 | 28.45 | 3.87 | 22.96 | Upgrade
|
| Tangible Book Value Per Share | 0.01 | 0.05 | 0.22 | 0.19 | 2.36 | Upgrade
|
| Machinery | - | 0.36 | 0.12 | 0.12 | 0.12 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.